Open Access

Expression of cancer-associated fibroblast markers in advanced colorectal cancer

  • Authors:
    • Rie Nishishita
    • Satoko Morohashi
    • Hiroko Seino
    • Yunyan Wu
    • Tadashi Yoshizawa
    • Toshihiro Haga
    • Kensuke Saito
    • Kenichi Hakamada
    • Shinsaku Fukuda
    • Hiroshi Kijima
  • View Affiliations

  • Published online on: February 21, 2018     https://doi.org/10.3892/ol.2018.8097
  • Pages: 6195-6202
  • Copyright: © Nishishita et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer is one of the most common causes of mortality from cancer worldwide. Previous studies have demonstrated that cancer-associated fibroblasts (CAFs) promote neoangiogenesis and tumor growth for various tumors. The present study analyzed CAF markers, including α‑smooth muscle actin (α‑SMA), collagen I, platelet‑derived growth factor receptor‑β (PDGFR‑β), and D2‑40 (antibody recognizing podoplanin), and vessel markers, including cluster of differentiation (CD)31 and CD34, for 121 advanced colorectal cancer cases using a digital image analyzing technique. The association between CAF markers and vessel markers with clinicopathological factors was investigated. Furthermore, the association between CAF markers with each other, and their association with vessel markers was analyzed. Mean/median expression area of stromal and vessel markers in tumors were collagen I, 26.787%; D2‑40, 1.372%; PDGFR‑β, 11.646%; α‑SMA‑positive and desmin‑negative myofibroblasts (α‑SMA subtraction), 15.372%; CD31, 3.635%; and CD34, 2.226%. The expression area of α‑SMA subtraction was significantly correlated with collagen I (P<0.001, correlation rho=0.509). High levels of α‑SMA subtraction (P=0.002), collagen I (P=0.040), and PDGFR‑β (P=0.040) expressions tended to be associated with high venous invasion. D2‑40 did not correlate with other CAF and vessel markers. These results indicated that individual CAFs may have different expression patterns, and different strength effects for venous invasion in advanced colorectal cancer stroma.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nishishita R, Morohashi S, Seino H, Wu Y, Yoshizawa T, Haga T, Saito K, Hakamada K, Fukuda S, Kijima H, Kijima H, et al: Expression of cancer-associated fibroblast markers in advanced colorectal cancer. Oncol Lett 15: 6195-6202, 2018.
APA
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T. ... Kijima, H. (2018). Expression of cancer-associated fibroblast markers in advanced colorectal cancer. Oncology Letters, 15, 6195-6202. https://doi.org/10.3892/ol.2018.8097
MLA
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T., Saito, K., Hakamada, K., Fukuda, S., Kijima, H."Expression of cancer-associated fibroblast markers in advanced colorectal cancer". Oncology Letters 15.5 (2018): 6195-6202.
Chicago
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T., Saito, K., Hakamada, K., Fukuda, S., Kijima, H."Expression of cancer-associated fibroblast markers in advanced colorectal cancer". Oncology Letters 15, no. 5 (2018): 6195-6202. https://doi.org/10.3892/ol.2018.8097